Surgery for oesophageal cancer: Current controversies;Chirurgie du cancer de l'œsophage: Controverses actuelles

Annales de Chirurgie

Volumn 128, Issue 6, 2003, Pages 351-358

  Thomas, P ^a   Acri, P ^a   Doddoli, C ^a   D'Journo, B ^a   Trousse, D ^a   Michelet, P ^a   Chetaille, B ^a   Papazian, L ^a   Giovannini, M ^b   Seitz, J F ^c   Giudicelli, R ^a   Fuentes, P ^a  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b INSTITUT PAOLI CALMETTES   (France)

^c TIMONE HOSPITAL   (France)

Author keywords

Combined modalities; Oesophageal cancer; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; DYSPHAGIA; ENDOSCOPIC SURGERY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; HISTOLOGY; HUMAN; LYMPHADENECTOMY; MEDIASTINUM; MULTIMODALITY CANCER THERAPY; NECK; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; SALVAGE THERAPY; SURGICAL APPROACH; TREATMENT INDICATION;

EID: 0042364842     PISSN: 00033944     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-3944(03)00122-6     Document Type: Review

References (87)

1. Fuentes P, Giudicelli R, Fogliani J, Reboud E. La chirurgie du cancer de l'œsophage méthodes et techniques. Ann Anesthesiol Fr 1977;18:369-72.
2. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;18(340):825-31.
3. Gudlaugsdottir S, van Blankenstein M, Dees J, Wilson JH. A majority of patients with Barrett's oesophagus are unlikely to benefit from endoscopic cancer surveillance. Eur J Gastro-enterol Hepatol 2001;13:639-45.
4. Lambert R. Endoscopic mucosectomy: an alternative treatment for superficial esophageal cancer. Recent Results Cancer Res 2000;155:183-92.
5. Étienne J, Dorme N, Bourg-Heckly G, Raimbert P, Fekete F. Traitement curatif local des adénocarcinomes superficiels sur endobrachyoesophage. Premiers résultats de thérapie photodynamique avec un nouveau photosensibilisateur. Bull Acad Natl Med 2000;184:1731-44.
6. Thomas P, Doddoli C, Lienne P, Morati N, Thirion X, Garbe L, et al. Changing patterns and surgical results in adenocarcinoma of the oesophagus. Br J Surg 1997;84:119-25.
7. Headrick JR, Nichols 3rd FC, Miller DL, Allen MS, Trastek VF, Deschamps C, Schleck CD, Thompson AM, Pairolero PC. High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy. Ann Thorac Surg 2002;73:1697-702.
8. Heitmiller RF, Sharma RR. Comparison of prevalence and resection rates in patients with esophageal squamous cell carcinoma and adenocarcinoma. J Thorac Cardiovasc Surg 1996;112:130-6.
9. Altorki N, Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma? Ann Surg 2001;234:581-7.
10. Ferguson MK, Durkin AE. Pre-operative prediction of the risk of pulmonary complications after esophagectomy for cancer. J Thorac Cardiovasc Surg 2002;123:661-9.
11. Doty JR, Salazar JD, Forastiere AA, Heath EI, Kleinberg L, Heitmiller RF. Postesophagectomy morbidity, mortality, and length of hospital stay after pre-operative chemoradiation therapy. Ann Thorac Surg 2002;74:227-31.
12. Poon RT, Law SY, Chu KM, Branicki FJ, Wong J. Esophagectomy for carcinoma of the esophagus in the elderly: results of current surgical management. Ann Surg 1998;227:357-64.
13. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg 1980;67:381-90.
14. Muller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H, Surgical therapy of oesophageal carcinoma. Br J Surg 1990;77:845-57.
15. Peracchia A, Bonavina L, Ruol A, Stein H, Esophageal cancer: an European perspective. Recent Results Cancer Res 2000;155:119-22.
16. Giudicelli R, Fuentes P, Thomas P, Dupin B, Fulachier V, Barthelemy A, et al. L'œsophagoplastie gastrique dans le traitement des cancers de l'œsophage. Ann Chir 1990;44:475-9.
17. Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346:1128-37.
18. Bailey SH, Bull DA, Harpole DH, Rentz JJ, Neumayer LA, Pappas TN, et al, Outcomes After Esophagectomy: A Ten-Years Prospective Cohort. Ann Thorac Surg 2003;75:217-22.
19. Kinoshita Y, Udagawa H, Tsutsumi K, Ueno M, Nakamura T, Akiyama H, et al. Usefulness of autologous blood transfusion for avoiding allogenic transfusion and infectious complications after esophageal cancer resection. Surgery 2000;127:185-92.
20. Bolton JS, Ochsner JL, Abdoh AA. Surgical management of esophageal cancer. A decade of change. Ann Surg 1994;219:475-80.
21. Karl RC, Schreiber R, Boulware D, Baker S, Coppola D. Factors affecting morbidity, mortality, and survival in patients undergoing Ivor Lewis esophagogastrectomy. Ann Surg 2000;231:635-43.
22. Thomas P, Doddoli C, Neville P, Pons J, Lienne P, Giudicelli R, et al. Esophageal cancer resection in the elderly. Eur J Cardiothorac Surg 1996;10:941-6.
23. Sabel MS, Smith JL, Nava HR, Mollen K, Douglass HO, Gibbs JF. Esophageal resection for carcinoma in patients older than 70 years. Ann Surg Oncol 2002;9:210-4.
24. Kinugasa S, Tachibana M, Yoshimura H, Dhar DK, Shibakita M, Ohno S, et al. Esophageal resection in elderly esophageal carcinoma patients: improvement in postoperative complications. Ann Thorac Surg 2001;71:414-8.
25. Miller JD, Jain MK, de Gara CJ, et al. Effect of surgical experience on results of esophagectomy for esophageal carcinoma. J Surg Oncol 1997;65:20-1.
26. Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. Jama 1998;280:1747-51.
27. Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346:1128-37.
28. Dimick JB, Pronovost PJ, Cowan JA, Lipsett PA. Surgical volume and quality of care for esophageal resection: do high-volume hospitals have fewer complications? Ann Thorac Surg 2003;75:337-41.
29. Kuwano H, Sumiyoshi K, Sonoda K, Kitamura K, Tsutsui S, Toh Y, et al. Relationship between pre-operative assessment of organ function and postoperative morbidity in patients with oesophageal cancer. Eur J Surg 1998;164:581-6.
30. Whooley BP, Law S, Murthy SC, Alexandrou A, Wong J. Analysis of reduced death and complication rates after esophageal resection. Ann Surg 2001;233:338-44.
31. Nagawa H, Kobori O, Muto T. Prediction of pulmonary complications after transthoracic oesophagectomy. Br J Surg 1994;81:860-2.
32. Avendano CE, Flume PA, Silvestri GA, King LB, Reed CE. Pulmonary complications after esophagectomy. Ann Thorac Surg 2002;73:922-6.
33. Tandon S, Batchelor A, Bullock R, Gascoigne A, Griffin M, Hayes N, et al. Peri-operative risk factors for acute lung injury after elective oesophagectomy. Br J Anaesth 2001;86:633-8.
34. Hulscher JB, ter Hofstede E, Kloek J, Obertop H, De Haan P, Van Lanschot JJ. Injury to the major airways during subtotal esophagectomy: incidence, management, and sequelae. J Thorac Cardiovasc Surg 2000;120:1093-6.
35. Kyriazanos ID, Tachibana M, Yoshimura H, Kinugasa S, Dhar DK, Nagasue N. Impact of splenectomy on the early outcome after oesophagectomy for squamous cell carcinoma of the oesophagus. Eur J Surg Oncol 2002;28:113-9.
36. Hulscher JB, van Sandick JW, Devriese PP, van Lanschot JJ, Obertop H. Vocal cord paralysis after subtotal oesophagectomy. Br J Surg 1999;86:1583-7.
37. Urschel JD, Urschel DM, Miller JD, Bennett WF, Young JE. A meta-analysis of randomized controlled trials of route of reconstruction after esophagectomy for cancer. Am J Surg 2001;182:470-5.
38. Kita T, Mammoto T, Kishi Y. Fluid management and postoperative respiratory disturbances in patients with transthoracic esophagectomy for carcinoma. J Clin Anesth 2002;14:252-6.
39. Caldwell MT, Murphy PG, Page R, Walsh TN, Hennessy TP, Timing of extubation after oesophagectomy. Br J Surg 1993;80:1537-9.
40. Watson A, Allen PR. Influence of thoracic epidural analgesia on outcome after resection for esophageal cancer. Surgery 1994;115:429-32.
41. Whooley BP, Law S, Murthy SC, Alexandrou A, Wong J. Analysis of reduced death and complication rates after esophageal resection. Ann Surg 2001;233:338-44.
42. Fagevik Olsen M, Wennberg E, Johnsson E, Josefson K, Lonroth H, Lundell L. Randomized clinical study of the prevention of pulmonary complications after thoraco-abdominal resection by 2 different breathing techniques. Br J Surg 2002;89:1228-34.
43. Papazian L, Fraisse A, Garbe L, Zandotti C, Thomas P, Saux P, et al. Cytomegalovirus. An unexpected cause of ventilator-associated pneumonia. Anesthesiology 1996;84:280-7.
44. Papazian L, Thomas P, Bregeon F, Garbe L, Zandotti C, Saux P, et al. Open-lung biopsy in patients with acute respiratory distress syndrome. Anesthesiology 1998;88:935-44.
45. Sielezneff I, Thomas P, Giovannini M, Giudicelli R, Seitz JF, Fuentes P. Esophageal carcinoma with doubtful extirpability. Value of pre-operative chemotherapy plus radiotherapy. Eur J Cardiothorac Surg 1993;7:606-11.
46. Urschel JD, Blewett CJ, Bennett WF, Miller JD, Young JE. Handsewn or stapled esophagogastric anastomoses after esophagectomy for cancer: meta-analysis of randomized controlled trials. Dis Esophagus 2001;14:212-7.
47. Fujita H, Kakegawa T, Yamana H, et al. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Ann Surg 1995;222:654-62.
48. Fuentes P. Invited commentary of "Current management of postoperative chylothorax by Fahimi H, Casselman FP, Mariani MA, van Boven WJ, Knaepen PJ, van Swieten HA. Ann Thorac Surg 2001;71:448-50. Ann Thorac Surg 2001;71:450-1.
49. Fuentes P. Invited commentary of "Current management of postoperative chylothorax by Fahimi H, Casselman FP, Mariani MA, van Boven WJ, Knaepen PJ, van Swieten HA. Ann Thorac Surg 2001;71:448-50. Ann Thorac Surg 2001;71:450-1.
50. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleadingstatistics for survival in cancer. N Engl J Med 1985;312:1604-8.
51. Herskovic A, Martz K, al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, Cooper J, Byhardt R, Davis L, Emami B. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-8.
52. Orringer MB. Ten-year survival after esophagectomy for carcinoma. Surgical triumph or biologic variation? Chest 1989;96:970-1.
53. Hulscher JBF, Tijssen JCP, Obertop H, van Lanschot J. Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. JB. Ann Thorac Surg 2001;72:306-13.
54. Hulscher JB, van Sandick JW, de Boer AG, Wijnhoven BP, Tijssen JG, Fockens P, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347:1662-9.
55. Law S, Wong J. Use of minimally invasive oesophagectomy for cancer of the oesophagus. Lancet Oncol 2002;3:215-22.
56. Reboud E, Pradoura JP, Fuentes P, Giudicelli R. Traitement chirurgical des cancers œsophagiens avoisinant la bouche de Killian. Ann Chir Thorac Cardiovasc 1978;17:48-52.
57. Peracchia A, Bonavina L, Botturi M, Pagani M, Via A, Saino G. Current status of surgery for carcinoma of the hypopharynx and cervical esophagus. Dis Esophagus 2001;14:95-7.
58. Izbicki JR, Hosch SB, Pichlmeier U, Rehders A, Busch C, Niendorf A, et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 1997;337:1188-94.
59. Akiyama H, Tsurumaru M, Udagawa H, et al. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994;220:364-72.
60. Nishihira T, Hirayama K, Mori S. A prospective randomised trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg 1998;175:47-51.
61. Altorki NK, Skinner DB. Occult cervical node metastasis in esophageal cancer: preliminary results of three-fields lymphadenectomy. J Thorac Cardiovasc Surg 1997;113:540-4.
62. Thomas P, Fuentes P, Giudicelli R, Reboud E. Colon interposition for esophageal replacement: current indications and long-term function. Ann Thorac Surg 1997;64:757-64.
63. Zieren HU, Muller JM, Jacobi CA, et al. Adjuvant postoperative radiation therapy after curative resection of squamous carcinoma of the thoracic esophagus: a prospective randomised study. World J Surg 1995;19:444-9.
64. Teniere P, Hay J -M, Fingerhut A, Fagniez PL. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. Surg Gynecol Obstet 1991;173:123-30.
65. Fok M, Sham JST, Choy D, et al. Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomised controlled study. Surgery 1993;113:138-47.
66. Xiao ZF, Yang ZY, Liang J, Miao YJ, Wang M, Yin WB, et al. Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg 2003;75:331-6.
67. Ando N, Iizuka T, Kakegawa T, Isono K, Watanabe H, lde H, et al. A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan clinical oncology group study. J Thorac Cardiovasc Surg 1997;114:205-9.
68. Arnott SJ, Duncan W, Gignoux M, et al. Pre-operative radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (Oesophageal cancer collaborative group). Int J Radiation Oncology Biol Phys 1998;41:579-83.
69. Anonymous. Surgical resection with or without pre-operative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002;359:1727-33.
70. Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998;339:1979-84.
71. Seitz JF, Giovannini M, Padaut-Cesana J, Fuentes P, Giudicelli R, Gauthier AP, et al. Inoperable nonmetastatic squamous cell carcinoma of the esophagus managed by concomitant chemotherapy (5-fluorouracil and cisplatin) and radiation therapy. Cancer 1990;66:214-9.
72. Geh JI, Crellin AM, Glynne-Jones R. Pre-operative (neo-adjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg 2001;88:338-56.
73. Nygaard K, Hagen S, Hansen HS, et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma. A randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992;16:1104-10.
74. Le Prise E, Etienne PL, Meunier B, et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994;73:1779-84.
75. Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locorcgional esophageal carcinoma. J Clin Oncol 2001;19:305-13.
76. Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462-7.
77. Bosset J-F, Gignoux M, Triboulet J-P, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell carcinoma of the esophagus. N Engl J Med 1997;337:161-7.
78. Law S, Kwong DLW, Tung HM, et al. Pre-operative chemoradiation for squamous cell esophageal cancer: a prospective randomized trial. Can J Gastro-enterol 1998;12(Suppl B):56B.
79. Thomas P, Doddoli C, Giacoia A, Garbe L, Perrier H, Giovannini M, et al. Traitement d'induction des cancers de l'œsophagc opérables localement avancés. Signification pronostique de la réponse histologique. Ann Chir 1997;51:222-31.
80. Giovannini M, Monges G, Seitz JF, Moutardier V, Bernardini D, Thomas P, et al. Distant lymph node metastases in esophageal cancer: impact of endoscopic ultrasound-guided biopsy. Endoscopy 1999;31:536-40.
81. Luketich JD, Schauer P, Landreneau R, et al. Minimally invasive surgical staging is superior to endoscopic ultrasound in detecting lymph node metastases in esophageal cancer. J Thorac Cardiovasc Surg 1997;114:817-23.
82. Block MI, Patterson GA, Sundaresen RS, et al. Improvement in staging esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg 1997;64:770-7.
83. Micallef J, Macquart-Moulin G, Auquier P, Seitz JF, Moatti JP. Mesure de la qualité de vie dans la chirurgie du cancerde l'œsopbage: revue critique de la littérature. Bull Cancer 1998;85:644-50.
84. Swisher SG, Wynn P, Putnam JB, Mosheim MB, Correa AM, Komaki RR, et al. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 2002;123:175-83.
85. Reed CE. Surgical management of esophageal carcinoma. The Oncologist 1999;4:95-105.
86. Lerut T, Coosemans W, De Leyn P, van Raemdonck D, Deneffe G, Decker G. Treatment of oesophageal carcinoma. Chest 1999;116:463S-5S.
87. Entwistle III JWC, Goldberg M. Multimodality therapy for resectable cancer of the thoracic esophagus. Ann Thomc Surg 2002;73:1009-15.